International Journal of Infertility & Fetal Medicine

Register      Login

VOLUME 6 , ISSUE 1 ( January-April, 2015 ) > List of Articles

RESEARCH ARTICLE

Combined Tamoxifen and L-Carnitine Therapies for the Treatment of Idiopathic Male Infertility Attending Intracytoplasmic Sperm Injection: A Randomized Controlled Trial

Milat Haje, Kameel Naoom

Citation Information : Haje M, Naoom K. Combined Tamoxifen and L-Carnitine Therapies for the Treatment of Idiopathic Male Infertility Attending Intracytoplasmic Sperm Injection: A Randomized Controlled Trial. Int J Infertil Fetal Med 2015; 6 (1):20-24.

DOI: 10.5005/jp-journals-10016-1096

Published Online: 00-04-2015

Copyright Statement:  Copyright © 2015; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Aim

The aim of the present study is to evaluate the fertility outcomes of intracytoplasmic sperm injection (ICSI) as well as sperm count, motility and morphology in couples with infertile male partners exhibiting idiopathic oligoasthenozoospermia (OA) and treated with tamoxifen citrate and/or L-carnitine.

Materials and methods

In this randomized controlled trail, couples with female cause of infertility were excluded. Only couples with male cause of infertility with idiopathic OA were admitted to this study and randomly assigned into four different groups of treatments as follow: Group A (n = 45) received an anti-estrogen compound (tamoxifen 20 mg/day), group B (n = 20) received L-carnitine (1000 mg/day), group C (n = 34) received tamoxifen 20 mg/day plus L-carnitine 1000 mg/day, whereas group D (n = 29) received placebo. Treatments were continued for 3 to 6 months.

Results

Treatment groups of A, B, and C showed an overall improvement in the tested parameters of sperm when compared to the control group that showed an overall reduction in those parameters after termination of the treatment. In this context, sperm count increased from 7.58 ± 2.93 × 106/ml before treatment to 10.81 ± 1.84 × 106/ml after treatment in group A (p = 0.016). Similarly, sperm count increased from 5.32 ± 2.09 × 106/ml to 8.92 ± 2.29 × 106/ml in group C (p = 0.01). Patients from group C did not only have an improved total motility of sperm from 8.03 ± 1.59% to 13.78 ± 3.85% (p = 0.045) but also an improved sperm normal morphology from 0.88 ± 0.45% to 1.99 ± 0.71% (p = 0.026). Patients from group A or C exhibited an improved ICSI outcomes when compared to those in patients from group B or D (48.9 or 48.3 vs 16.6 or 20, respectively, p = 0.46).

Conclusion

It is concluded that administration of tamoxifen and L-carnitine can improve both sperm parameters of fertility and ICSI outcomes. Combined tamoxifen and L-carnitine treatments result in maximum therapeutic effect in men with idiopathic OA.

How to cite this article

Haje M, Naoom K. Combined Tamoxifen and L-Carnitine Therapies for the Treatment of Idiopathic Male Infertility Attending Intracytoplasmic Sperm Injection: A Randomized Controlled Trial. Int J Infertil Fetal Med 2015;6(1):20-24.


PDF Share
  1. Male infertility. In: Walsh PC, Retic AB, Vaughan ED. Jr, Wein AJ (eds Campbell's Urology. 8th ed. Philadelphia, WB Saunders Co, 2002.
  2. Androgen versus placebo or no treatment for idiopathic oligo/asthenozoospermia. Cochrane database sys review 2007.
  3. Aromatase inhibition in the human male reveals a hypothalamic site of estrogen feedback. J Clin Endocrinol Metab 2000;85(9):3027-3035.
  4. Aniestrogens. Pharmacol Ther 1981;12(3):439-447.
  5. Clomiphene citrate: a correlation of its effect on sperm concentration and morphology, total gonadotropins, ICSH, estrogen and testosterone excretion, and testicular cytology in normal men. J Clin Endocrinol Metab 1969;29(5):638-649.
  6. Carntintines and male infertility. Reprod Biomed online 2004;8(4):376-384.
  7. Nonsurgical treatment of male infertility: specific and impiric therapy. Biologics Targets and Therapy 2007;1(3):259-269.
  8. Combined conventional antioxidant astaxanthin treatment for male infertility: a double blind, randomized trial. Asian J Androl 2005;7(3):257-262.
  9. Effectiveness of combined tamoxifen citrate and testosterone undecanoate treatment in men with idiopathic oligozoospermia. Fertil Steril 2003;80(4):914-920.
  10. WHO laboratory manual for the examination of human semen and sperm-cervical mucus interaction. Ann 1st Super Sanita 2001;37(1):1-123.
  11. WHO laboratory manual for the examination of human semen and sperm-cervical mucus interaction. 4th Cambridge, University Press, Cambridge 1999.
  12. The present and future state of hormonal treatment for male infertility. Hum Reprod Update 2003;9(1):9-23.
  13. Combination clomiphene citrate and antioxidant therapy for idiopathic male infertility: a randomized controlled trial. Fertil Steril 2010;93(7):2232-2235.
  14. Treating idiopathic male infertility with a combination of tamoxifen citrate and a natural compost with antioxidant and androgen-mimetic action. J Steroids Hormons Sci; open access 2013;1-6.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.